nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—colon cancer	0.687	1	CbGaD
Pranlukast—ABCC2—Irinotecan—colon cancer	0.0468	0.275	CbGbCtD
Pranlukast—ABCC2—Vincristine—colon cancer	0.0409	0.24	CbGbCtD
Pranlukast—CYP2C9—Capecitabine—colon cancer	0.0255	0.15	CbGbCtD
Pranlukast—ABCC2—Methotrexate—colon cancer	0.0248	0.146	CbGbCtD
Pranlukast—CYP2C9—Fluorouracil—colon cancer	0.0151	0.0887	CbGbCtD
Pranlukast—CYP3A4—Irinotecan—colon cancer	0.00915	0.0537	CbGbCtD
Pranlukast—CYP3A4—Vincristine—colon cancer	0.00799	0.047	CbGbCtD
Pranlukast—MUC2—gall bladder—colon cancer	0.00539	0.0882	CbGeAlD
Pranlukast—ABCC2—bile—colon cancer	0.00435	0.0711	CbGeAlD
Pranlukast—IL5—epithelium—colon cancer	0.00363	0.0593	CbGeAlD
Pranlukast—MUC2—embryo—colon cancer	0.00342	0.0559	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—colon cancer	0.00308	0.0503	CbGeAlD
Pranlukast—RNASE3—digestive system—colon cancer	0.00304	0.0497	CbGeAlD
Pranlukast—RNASE3—bone marrow—colon cancer	0.0028	0.0458	CbGeAlD
Pranlukast—IL5—lymphoid tissue—colon cancer	0.00279	0.0457	CbGeAlD
Pranlukast—MUC2—epithelium—colon cancer	0.00279	0.0456	CbGeAlD
Pranlukast—IL5—digestive system—colon cancer	0.00276	0.0451	CbGeAlD
Pranlukast—MUC2—renal system—colon cancer	0.00259	0.0423	CbGeAlD
Pranlukast—MUC2—digestive system—colon cancer	0.00212	0.0347	CbGeAlD
Pranlukast—TNF—vagina—colon cancer	0.00187	0.0306	CbGeAlD
Pranlukast—MUC2—liver—colon cancer	0.00158	0.0258	CbGeAlD
Pranlukast—IL5—lymph node—colon cancer	0.00158	0.0258	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—colon cancer	0.0015	0.0246	CbGeAlD
Pranlukast—NFKB1—renal system—colon cancer	0.00147	0.0241	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—colon cancer	0.00122	0.02	CbGeAlD
Pranlukast—TNF—lymph node—colon cancer	0.00121	0.0198	CbGeAlD
Pranlukast—NFKB1—digestive system—colon cancer	0.00121	0.0198	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—colon cancer	0.0012	0.0197	CbGeAlD
Pranlukast—NFKB1—bone marrow—colon cancer	0.00111	0.0182	CbGeAlD
Pranlukast—CYSLTR1—bone marrow—colon cancer	0.0011	0.0179	CbGeAlD
Pranlukast—NFKB1—vagina—colon cancer	0.00107	0.0175	CbGeAlD
Pranlukast—CYSLTR1—vagina—colon cancer	0.00105	0.0172	CbGeAlD
Pranlukast—NFKB1—liver—colon cancer	0.000901	0.0147	CbGeAlD
Pranlukast—NFKB1—lymph node—colon cancer	0.000691	0.0113	CbGeAlD
Pranlukast—CYSLTR1—lymph node—colon cancer	0.000679	0.0111	CbGeAlD
Pranlukast—ABCC2—renal system—colon cancer	0.000579	0.00947	CbGeAlD
Pranlukast—ABCC2—digestive system—colon cancer	0.000475	0.00777	CbGeAlD
Pranlukast—ABCC2—liver—colon cancer	0.000354	0.00579	CbGeAlD
Pranlukast—CYP2C9—digestive system—colon cancer	0.000316	0.00517	CbGeAlD
Pranlukast—CYP3A4—renal system—colon cancer	0.000294	0.00481	CbGeAlD
Pranlukast—ABCC2—lymph node—colon cancer	0.000271	0.00444	CbGeAlD
Pranlukast—CYP3A4—digestive system—colon cancer	0.000241	0.00395	CbGeAlD
Pranlukast—CYP2C9—liver—colon cancer	0.000236	0.00385	CbGeAlD
Pranlukast—Candesartan—ABCB1—colon cancer	0.000221	1	CrCbGaD
Pranlukast—CYP3A4—liver—colon cancer	0.00018	0.00294	CbGeAlD
Pranlukast—TNF—SIDS Susceptibility Pathways—EP300—colon cancer	4.45e-05	0.000544	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—KRAS—colon cancer	4.43e-05	0.000542	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—colon cancer	4.41e-05	0.00054	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—colon cancer	4.41e-05	0.00054	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.33e-05	0.000529	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.32e-05	0.000528	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—colon cancer	4.29e-05	0.000525	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDH1—colon cancer	4.28e-05	0.000524	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—colon cancer	4.26e-05	0.000521	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KRAS—colon cancer	4.25e-05	0.00052	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.23e-05	0.000518	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	4.22e-05	0.000517	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.21e-05	0.000515	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—colon cancer	4.16e-05	0.000509	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD8A—colon cancer	4.15e-05	0.000508	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—PIK3CA—colon cancer	4.15e-05	0.000507	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	4.11e-05	0.000503	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—colon cancer	4.1e-05	0.000502	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—colon cancer	4.09e-05	0.0005	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	4.07e-05	0.000498	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN1A—colon cancer	4.03e-05	0.000493	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CASP3—colon cancer	4.01e-05	0.000491	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—colon cancer	4.01e-05	0.000491	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4e-05	0.000489	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—colon cancer	3.98e-05	0.000487	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.98e-05	0.000486	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA7—colon cancer	3.95e-05	0.000484	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—colon cancer	3.94e-05	0.000482	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KRAS—colon cancer	3.93e-05	0.000481	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NRAS—colon cancer	3.92e-05	0.00048	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—PIK3CA—colon cancer	3.9e-05	0.000478	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	3.87e-05	0.000473	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—colon cancer	3.84e-05	0.000469	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—EP300—colon cancer	3.83e-05	0.000469	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—colon cancer	3.8e-05	0.000465	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—colon cancer	3.78e-05	0.000463	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.78e-05	0.000463	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CDKN1A—colon cancer	3.78e-05	0.000462	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—colon cancer	3.78e-05	0.000462	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—colon cancer	3.76e-05	0.00046	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2L1—colon cancer	3.7e-05	0.000453	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3.68e-05	0.00045	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.67e-05	0.000449	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MYC—colon cancer	3.65e-05	0.000447	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—colon cancer	3.64e-05	0.000446	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—colon cancer	3.63e-05	0.000444	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—colon cancer	3.63e-05	0.000444	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—colon cancer	3.62e-05	0.000443	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—PIK3CA—colon cancer	3.61e-05	0.000442	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	3.61e-05	0.000442	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	3.61e-05	0.000441	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.58e-05	0.000438	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—colon cancer	3.57e-05	0.000437	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.55e-05	0.000435	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PPARG—colon cancer	3.55e-05	0.000434	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGFR3—colon cancer	3.54e-05	0.000433	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—SRC—colon cancer	3.5e-05	0.000428	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—NRAS—colon cancer	3.42e-05	0.000418	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGFR3—colon cancer	3.4e-05	0.000416	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—colon cancer	3.39e-05	0.000414	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—KRAS—colon cancer	3.38e-05	0.000413	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRAS—colon cancer	3.36e-05	0.000411	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—colon cancer	3.34e-05	0.000409	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	3.34e-05	0.000409	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—colon cancer	3.33e-05	0.000407	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	3.3e-05	0.000403	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	3.29e-05	0.000402	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGFR3—colon cancer	3.28e-05	0.000401	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	3.22e-05	0.000394	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—colon cancer	3.2e-05	0.000391	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	3.19e-05	0.00039	CbGpPWpGaD
Pranlukast—IL5—Immune System—CTNNB1—colon cancer	3.16e-05	0.000387	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDKN1A—colon cancer	3.09e-05	0.000378	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.08e-05	0.000376	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—colon cancer	3.06e-05	0.000375	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.05e-05	0.000373	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APC—colon cancer	3.01e-05	0.000368	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NRAS—colon cancer	3.01e-05	0.000368	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3e-05	0.000367	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—colon cancer	3e-05	0.000367	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—colon cancer	2.95e-05	0.000361	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	2.95e-05	0.000361	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—colon cancer	2.94e-05	0.00036	CbGpPWpGaD
Pranlukast—IL5—Immune System—EP300—colon cancer	2.94e-05	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—colon cancer	2.9e-05	0.000354	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDH1—colon cancer	2.87e-05	0.000351	CbGpPWpGaD
Pranlukast—IL5—Immune System—SRC—colon cancer	2.86e-05	0.00035	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BRAF—colon cancer	2.83e-05	0.000346	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.8e-05	0.000342	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRAS—colon cancer	2.75e-05	0.000336	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—colon cancer	2.74e-05	0.000336	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—colon cancer	2.74e-05	0.000335	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.71e-05	0.000331	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—PIK3CA—colon cancer	2.71e-05	0.000331	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARG—colon cancer	2.7e-05	0.000331	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—colon cancer	2.7e-05	0.000331	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PIK3CA—colon cancer	2.66e-05	0.000325	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—PIK3CA—colon cancer	2.62e-05	0.000321	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA7—colon cancer	2.61e-05	0.000319	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—colon cancer	2.59e-05	0.000317	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—colon cancer	2.53e-05	0.00031	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—colon cancer	2.52e-05	0.000308	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—colon cancer	2.51e-05	0.000306	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—colon cancer	2.5e-05	0.000306	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CTNNB1—colon cancer	2.5e-05	0.000306	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—colon cancer	2.46e-05	0.000301	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CHST5—colon cancer	2.4e-05	0.000293	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ODC1—colon cancer	2.4e-05	0.000293	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PIK3CA—colon cancer	2.38e-05	0.000291	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—colon cancer	2.37e-05	0.00029	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGFR3—colon cancer	2.35e-05	0.000288	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EP300—colon cancer	2.32e-05	0.000284	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.29e-05	0.00028	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SRC—colon cancer	2.26e-05	0.000276	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CTNNB1—colon cancer	2.21e-05	0.00027	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—colon cancer	2.2e-05	0.000269	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—colon cancer	2.2e-05	0.000269	CbGpPWpGaD
Pranlukast—IL5—Immune System—PIK3CA—colon cancer	2.17e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—colon cancer	2.17e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NRAS—colon cancer	2.17e-05	0.000266	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APC—colon cancer	2.16e-05	0.000264	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NRAS—colon cancer	2.16e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDKN1A—colon cancer	2.16e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2L1—colon cancer	2.16e-05	0.000264	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—colon cancer	2.14e-05	0.000262	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CASP3—colon cancer	2.12e-05	0.000259	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDKN1A—colon cancer	2.07e-05	0.000253	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—colon cancer	2.06e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGFR3—colon cancer	2.06e-05	0.000252	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EP300—colon cancer	2.05e-05	0.000251	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CTNNB1—colon cancer	2.04e-05	0.00025	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BRAF—colon cancer	2.03e-05	0.000248	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—colon cancer	2.02e-05	0.000247	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—colon cancer	2.01e-05	0.000246	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN1A—colon cancer	2e-05	0.000244	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—SRC—colon cancer	1.99e-05	0.000244	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—colon cancer	1.98e-05	0.000242	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—colon cancer	1.97e-05	0.000241	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—colon cancer	1.94e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRAS—colon cancer	1.92e-05	0.000235	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—SRC—colon cancer	1.91e-05	0.000234	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CTNNB1—colon cancer	1.9e-05	0.000233	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EP300—colon cancer	1.9e-05	0.000232	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—colon cancer	1.88e-05	0.00023	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—colon cancer	1.87e-05	0.000229	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—colon cancer	1.86e-05	0.000227	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SRC—colon cancer	1.85e-05	0.000226	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRAS—colon cancer	1.84e-05	0.000225	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—colon cancer	1.8e-05	0.00022	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRAS—colon cancer	1.78e-05	0.000217	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—colon cancer	1.78e-05	0.000217	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EP300—colon cancer	1.77e-05	0.000216	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—colon cancer	1.75e-05	0.000214	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDH1—colon cancer	1.74e-05	0.000213	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SRC—colon cancer	1.72e-05	0.00021	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PIK3CA—colon cancer	1.71e-05	0.000209	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—colon cancer	1.68e-05	0.000205	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—colon cancer	1.68e-05	0.000205	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—colon cancer	1.66e-05	0.000203	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NRAS—colon cancer	1.66e-05	0.000202	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—colon cancer	1.65e-05	0.000202	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—colon cancer	1.65e-05	0.000202	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—colon cancer	1.62e-05	0.000198	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—colon cancer	1.59e-05	0.000194	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—colon cancer	1.59e-05	0.000194	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—colon cancer	1.58e-05	0.000193	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CHST5—colon cancer	1.58e-05	0.000193	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ODC1—colon cancer	1.58e-05	0.000193	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—colon cancer	1.54e-05	0.000188	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—colon cancer	1.54e-05	0.000188	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—colon cancer	1.53e-05	0.000187	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CASP3—colon cancer	1.52e-05	0.000186	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PIK3CA—colon cancer	1.52e-05	0.000186	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—colon cancer	1.51e-05	0.000184	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—colon cancer	1.48e-05	0.000181	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CTNNB1—colon cancer	1.47e-05	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PIK3CA—colon cancer	1.46e-05	0.000178	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN1A—colon cancer	1.43e-05	0.000175	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—colon cancer	1.42e-05	0.000174	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CA—colon cancer	1.41e-05	0.000172	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—colon cancer	1.4e-05	0.000172	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—colon cancer	1.4e-05	0.000172	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—colon cancer	1.4e-05	0.000171	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EP300—colon cancer	1.36e-05	0.000167	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—colon cancer	1.36e-05	0.000166	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—colon cancer	1.35e-05	0.000165	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGFR3—colon cancer	1.33e-05	0.000163	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SRC—colon cancer	1.33e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—colon cancer	1.3e-05	0.000159	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—colon cancer	1.29e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTNNB1—colon cancer	1.29e-05	0.000157	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRAS—colon cancer	1.28e-05	0.000156	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDKN1A—colon cancer	1.26e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—colon cancer	1.24e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APC—colon cancer	1.22e-05	0.00015	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—colon cancer	1.21e-05	0.000148	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EP300—colon cancer	1.19e-05	0.000146	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—colon cancer	1.19e-05	0.000146	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—colon cancer	1.19e-05	0.000145	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—colon cancer	1.19e-05	0.000145	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—colon cancer	1.16e-05	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SRC—colon cancer	1.16e-05	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BRAF—colon cancer	1.15e-05	0.000141	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—colon cancer	1.15e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRAS—colon cancer	1.12e-05	0.000137	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—colon cancer	1.1e-05	0.000134	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—colon cancer	1.07e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—colon cancer	1.02e-05	0.000125	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CA—colon cancer	1.01e-05	0.000123	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.89e-06	0.000121	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—colon cancer	9.76e-06	0.000119	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—colon cancer	9.62e-06	0.000118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—colon cancer	9.33e-06	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PIK3CA—colon cancer	8.84e-06	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CASP3—colon cancer	8.62e-06	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—colon cancer	8.39e-06	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNB1—colon cancer	8.31e-06	0.000102	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—colon cancer	8.24e-06	0.000101	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—colon cancer	8.17e-06	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN1A—colon cancer	8.12e-06	9.93e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.78e-06	9.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EP300—colon cancer	7.72e-06	9.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SRC—colon cancer	7.51e-06	9.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—colon cancer	7.31e-06	8.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRAS—colon cancer	7.22e-06	8.84e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—colon cancer	7.22e-06	8.83e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—colon cancer	6.73e-06	8.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—colon cancer	6.71e-06	8.21e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—colon cancer	6.58e-06	8.05e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.47e-06	7.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—colon cancer	6.33e-06	7.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—colon cancer	6.22e-06	7.61e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TYMS—colon cancer	6.22e-06	7.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CA—colon cancer	5.71e-06	6.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—colon cancer	5.53e-06	6.76e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—colon cancer	5.29e-06	6.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.79e-06	5.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—colon cancer	4.67e-06	5.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—colon cancer	4.4e-06	5.39e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—colon cancer	4.18e-06	5.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TYMS—colon cancer	4.1e-06	5.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—colon cancer	3.47e-06	4.24e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—colon cancer	2.9e-06	3.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—EP300—colon cancer	2.88e-06	3.53e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—colon cancer	2.29e-06	2.8e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CA—colon cancer	2.13e-06	2.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—EP300—colon cancer	1.9e-06	2.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—colon cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CA—colon cancer	1.41e-06	1.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—colon cancer	1.15e-06	1.4e-05	CbGpPWpGaD
